HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Sodium naproxen

HCID 9837916
New reaction
Print
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
26159-34-2
Standard SMILES
COc1ccc2cc([C@H](C)C(=O)O)ccc2c1.[Na]
InChIKey
CNQOEXOJUIMDHW-FVGYRXGTSA-N
Molecular formula
C14H14NaO3
Average molar mass
253.25 g/mol
Monoisotopic mass
253.08406359

Names & identifiers

Preferred name
Sodium naproxen
English name
Naproxen sodium
Molecular formula
C14H13O3.Na
Molecular weight
253.25

Names & synonyms

sodium naproxenCNQOEXOJUIMDHW-FVGYRXGTSA-NaleveNaprelanAnax(S)-6-METHOXY-ALPHA-METHYL-2-NAPHTHALENEACETIC ACID SODIUM SALTAnaproxaproxen sodiumNAPROXENSODIUM,USPNAPROXEN SODIUM SALTNaproxen Sodium (200 mg)Naproxen Sodium (1457403)

Database identifiers

CAS
26159-34-2
PubChem CID
9837916

Properties

Computed structural properties

Topological polar surface area
46.5 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
3
Heavy atoms
18
Formal charge
0
Complexity
277

Physicochemical properties

Melting point
250 · 250-251°C
alpha
-11 ° · D -11° (in methanol)
Density
1.2 g/cm³ · 1.2 g/cm³
storage temp.
Inert atmosphere,Room Temperature
solubility
Freely soluble in water, freely soluble or soluble in methanol, sparingly soluble in ethanol (96 per cent).
form
Solid
color
White to Off-White
biological source
synthetic (organic)
Water Solubility
100 mg/mlSoluble · Soluble in water up to 100mg/mlSoluble in methanol and chloroform. Slightly soluble in ether. Insoluble in water.
Major Application
pharmaceutical (small molecule)
InChI
InChI=1/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/s3
InChIKey
CDBRNDSHEYLDJV-OVMXBOEKNA-M
SMILES
C12C=CC(OC)=CC1=CC=C([C@H](C)C([O-])=O)C=2.[Na+] |&1:11,r|
CAS DataBase Reference

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
rtecs
QJ1047000
ridadr
3249
hs_code
2918992090
risk_code
22-61
Signal word
Danger
Symbol(GHS)
GHS07,GHS08
hazard_code
Xn,T
safety_code
53-45
hazard_class
6.1(b)
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
III
Hazard statements
H302-H360
Hazard Classifications
Acute Tox. 4 OralRepr. 1A
Precautionary statements
P201-P202-P264-P270-P301+P312-P308+P313

Chemistry & industry

Applications · 5 items

UsesUsed as anti-inflammatory analgesic

UsesNaproxen (Aleve, Anaprox) is a COX inhibitor for COX-1 and COX-2 with IC50 of 8.7 μM and 5.2 μM, respectively

UsesA cyclooxygenase inhibitorNaproxen sodium acts as a nonselective inhibitor of Cox-1 and Cox-2. It serves as an anti-inflammatory agent with analgesic and antipyretic properties. Further, it is used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea and acute gout.

UsesAn anti-inflammatory, analgesic, antipyretic. A non-steroidal anti-inflammatory

General DescriptionNaproxen sodium (NS) is a sodium salt of propionic acid derivative and demonstrates analgesic, anti-pyretic, and anti-inflammatory properties. It exhibits efficiency in being used as an indomethacin in the treatment of acute musculoskeletal disorders. It belongs to the group of nonsteroidal anti-inflammatory drugs (NSAIDS) and acts by inhibiting the activity of both the cyclooxygenase enzymes, COX-1 & COX-2 and further blocking the synthesis of certain prostaglandins. It is administered in the treatment of ankylosing spondylitis, osteoarthritis, rheumatoid disorders, acute gout, mild to moderate pain, tendonitis, bursitis, dysmenorrhea, fever, and migraine headache. Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

Upstream & downstream products

Upstream raw materials

Naproxen

Downstream products

(S)-(+)-Naproxen chloride2,6-Di-O-methyl-beta-cyclodextrin

Additional notes

Related reactions

1 records
New reaction record
HRID 1585244 reaction equation
HRID 1585244As reactant

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
26159 · 26159-34-2(CAS DataBase Reference)
FDA UNII
9 TN87S3A3C · 9TN87S3A3C
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07,GHS08
Signal word
Danger
Hazard statements
302 · H302-H360
Precautionary statements
201 · P201-P202-P264-P270-P301+P312-P308+P313
PPE
95 · dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes
Xn,T
Risk Statements
22 · 22-61
Safety Statements
53 · 53-45
RIDADR
3249 · 3249
WGK Germany
3 · 3
RTECS
1047000 · QJ1047000
HazardClass
6.1 · 6.1(b)
PackingGroup
III
HS Code
2918992090 · 2918992090
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
4 OralRepr · Acute Tox. 4 OralRepr. 1A

DefinitionChEBI: The sodium salt of naproxen.